1.Megalocytic Interstitial Nephritis Following Acute Pyelonephritis with Escherichia coli Bacteremia: A Case Report.
Hee Jin KWON ; Kwai Han YOO ; In Young KIM ; Seulkee LEE ; Hye Ryoun JANG ; Ghee Young KWON
Journal of Korean Medical Science 2015;30(1):110-114
Megalocytic interstitial nephritis is a rare form of kidney disease caused by chronic inflammation. We report a case of megalocytic interstitial nephritis occurring in a 45-yrold woman who presented with oliguric acute kidney injury and acute pyelonephritis accompanied by Escherichia coli bacteremia. Her renal function was not recovered despite adequate duration of susceptible antibiotic treatment, accompanied by negative conversion of bacteremia and bacteriuria. Kidney biopsy revealed an infiltration of numerous histiocytes without Michaelis-Gutmann bodies. The patient's renal function was markedly improved after short-term treatment with high-dose steroid.
Acute Disease
;
Acute Kidney Injury/complications/*drug therapy/pathology
;
Anti-Bacterial Agents/therapeutic use
;
Azithromycin/therapeutic use
;
Bacteremia/*drug therapy/microbiology/pathology
;
Cefotaxime/therapeutic use
;
Creatinine/blood
;
Escherichia coli
;
Escherichia coli Infections/*drug therapy/microbiology/pathology
;
Female
;
Humans
;
Kidney/pathology
;
Methylprednisolone/therapeutic use
;
Middle Aged
;
Nephritis, Interstitial/*drug therapy/immunology/pathology
;
Pyelonephritis/complications/*drug therapy/pathology
;
Renal Dialysis
;
Shock, Septic/drug therapy/microbiology
2.Combined Administration of Glutamine and Growth Hormone Synergistically Reduces Bacterial Translocation in Sepsis.
Sung Eun JUNG ; Yeo Kyu YOUN ; Yong Su LIM ; Hyoung Gon SONG ; Joong Eui RHEE ; Gil Joon SUH
Journal of Korean Medical Science 2003;18(1):17-22
We investigated the combined effect of glutamine (GLN) and growth hormone (GH) on bacterial translocation (BT) in sepsis. After single intraperitoneal injection of lipopolysaccharide (10 mg/kg), 48 rats were divided randomly into four groups of 12 animals each: the control group received chow orally; the GLN group received chow plus 10% GLN; GH group received chow plus GH; and the GLN/GH group received chow, 10% GLN, and GH. Twenty-four and 96 hr later, rats were sacrificed. Portal blood culture, bacterial colony counts of cultured mesenteric lymph nodes, mucosal thickness, malondialdehyde (MDA), and glutathione (GSH) levels in the gut mucosa were measured. There was no significant change of the rate of portal blood culture between all treatment groups at 24 and 96 hr. At 24 hr, the rats receiving combined treatment of GLN and GH showed lower bacterial colony counts and mucosal MDA levels than the control rats, and higher mucosal GSH levels than the control and GLN-treated rats. At 96 hr, rats treated with both GLN and GH exhibited lower bacterial colony counts and mucosal MDA levels, and higher mucosal thickness and GSH levels than control, GLN, or GH-treated rats. This study suggests that the combination of GLN and GH may synergistically reduce BT over time in sepsis.
Animals
;
Bacteremia/etiology
;
Bacteremia/microbiology
;
Bacteremia/prevention & control
;
Bacterial Translocation/drug effects*
;
Comparative Study
;
Drug Evaluation, Preclinical
;
Drug Synergism
;
Endotoxemia/drug therapy*
;
Endotoxemia/microbiology
;
Escherichia coli/isolation & purification*
;
Glutamine/pharmacology*
;
Glutamine/therapeutic use
;
Glutathione/analysis
;
Human Growth Hormone/pharmacology*
;
Human Growth Hormone/therapeutic use
;
Ileum/microbiology
;
Ileum/pathology
;
Intestinal Mucosa/microbiology
;
Intestinal Mucosa/pathology
;
Lipid Peroxidation/drug effects
;
Lymph Nodes/microbiology
;
Male
;
Rats
;
Rats, Sprague-Dawley
;
Recombinant Proteins/pharmacology
;
Recombinant Proteins/therapeutic use
;
Sepsis/microbiology
;
Sepsis/prevention & control*
;
Specific Pathogen-Free Organisms
3.A Case of Clostridium difficile Bacteremia in a Patient with Loop Ileostomy.
Jae Lim CHOI ; Bo Ram KIM ; Ji Eun KIM ; Kwang Sook WOO ; Kyeoung Hee KIM ; Jeong Man KIM ; Su Ee LEE ; Jin Yeong HAN
Annals of Laboratory Medicine 2013;33(3):200-202
Clostridium difficile, an anaerobic, spore-forming, gram-positive, rod-shaped bacterium, is the most common nosocomial pathogen causing pseudomembranous colitis. C. difficile is not intrinsically invasive and rarely infects extraintestinal sites. The bacterium, therefore, is not commonly detected in blood cultures. Here, we report a case of C. difficile bacteremia in a patient who had underwent loop ileostomy because of rectal obstruction following metastatic colon cancer originated from prostate cancer.
Anti-Bacterial Agents/*therapeutic use
;
Bacteremia/*drug therapy
;
Clostridium difficile/genetics/*isolation & purification
;
Colonic Neoplasms/pathology/secondary
;
Enterocolitis, Pseudomembranous/drug therapy/microbiology
;
Humans
;
Ileostomy
;
Male
;
Middle Aged
;
Prostatic Neoplasms/pathology
;
RNA, Ribosomal, 16S/chemistry/genetics
;
Sequence Analysis, RNA
4.A Case of Clostridium difficile Bacteremia in a Patient with Loop Ileostomy.
Jae Lim CHOI ; Bo Ram KIM ; Ji Eun KIM ; Kwang Sook WOO ; Kyeoung Hee KIM ; Jeong Man KIM ; Su Ee LEE ; Jin Yeong HAN
Annals of Laboratory Medicine 2013;33(3):200-202
Clostridium difficile, an anaerobic, spore-forming, gram-positive, rod-shaped bacterium, is the most common nosocomial pathogen causing pseudomembranous colitis. C. difficile is not intrinsically invasive and rarely infects extraintestinal sites. The bacterium, therefore, is not commonly detected in blood cultures. Here, we report a case of C. difficile bacteremia in a patient who had underwent loop ileostomy because of rectal obstruction following metastatic colon cancer originated from prostate cancer.
Anti-Bacterial Agents/*therapeutic use
;
Bacteremia/*drug therapy
;
Clostridium difficile/genetics/*isolation & purification
;
Colonic Neoplasms/pathology/secondary
;
Enterocolitis, Pseudomembranous/drug therapy/microbiology
;
Humans
;
Ileostomy
;
Male
;
Middle Aged
;
Prostatic Neoplasms/pathology
;
RNA, Ribosomal, 16S/chemistry/genetics
;
Sequence Analysis, RNA
5.Weissella confusa Bacteremia in an Immune-Competent Patient with Underlying Intramural Hematomas of the Aorta.
Wonmok LEE ; Sun Mi CHO ; Myungsook KIM ; Young Guk KO ; Dongeun YONG ; Kyungwon LEE
Annals of Laboratory Medicine 2013;33(6):459-462
No abstract available.
Anti-Bacterial Agents/therapeutic use
;
Aorta/pathology
;
Bacteremia/*complications/drug therapy/*microbiology
;
Ceftriaxone/therapeutic use
;
Female
;
Gram-Positive Bacterial Infections/*complications/drug therapy/*pathology
;
Hematoma/*complications
;
Humans
;
*Immunocompromised Host
;
Middle Aged
;
Phylogeny
;
RNA, Ribosomal, 16S/analysis
;
Sequence Analysis, DNA
;
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
;
Tomography, X-Ray Computed
;
Weissella/classification/genetics/isolation & purification/*physiology
6.The First Korean Case of Sphingobacterium spiritivorum Bacteremia in a Patient with Acute Myeloid Leukemia.
Young Rae KOH ; Shine Young KIM ; Chulhun L CHANG ; Ho Jin SHIN ; Kye Hyung KIM ; Jongyoun YI
Annals of Laboratory Medicine 2013;33(4):283-287
Sphingobacterium spiritivorum has been rarely isolated from clinical specimens of immunocompromised patients, and there have been no case reports of S. spiritivorum infection in Korea to our knowledge. We report a case of S. spiritivorum bacteremia in a 68-yr-old woman, who was diagnosed with acute myeloid leukemia and subsequently received chemotherapy. One day after chemotherapy ended, her body temperature increased to 38.3degrees C. A gram-negative bacillus was isolated in aerobic blood cultures and identified as S. spiritivorum by an automated biochemical system. A 16S rRNA sequencing analysis confirmed that the isolate was S. spiritivorum. The patient received antibiotic therapy for 11 days but died of septic shock. This is the first reported case of human S. spiritivorum infection in Korea. Although human infection is rare, S. spiritivorum can be a fatal opportunistic pathogen in immunocompromised patients.
Aged
;
Anti-Bacterial Agents/therapeutic use
;
Bacteremia/*complications/drug therapy/*microbiology
;
Bone Marrow Cells/pathology
;
Fatal Outcome
;
Female
;
Humans
;
Immunocompromised Host
;
Leukemia, Myeloid, Acute/*complications
;
Phylogeny
;
RNA, Ribosomal, 16S/genetics
;
Sequence Analysis, DNA
;
Shock, Septic/etiology/microbiology
;
Sphingobacterium/classification/genetics/isolation & purification/*physiology